IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,828,368 | +12.1% | 194,629 | +1.4% | 0.01% | +16.7% |
| Q2 2023 | $7,872,998 | +9.6% | 191,884 | -4.5% | 0.01% | 0.0% |
| Q1 2023 | $7,182,093 | -15.7% | 200,954 | -10.9% | 0.01% | -25.0% |
| Q4 2022 | $8,516,002 | -19.2% | 225,470 | -5.3% | 0.01% | -27.3% |
| Q3 2022 | $10,534,000 | +15.5% | 238,168 | -3.4% | 0.01% | +22.2% |
| Q2 2022 | $9,124,000 | -4.0% | 246,449 | -4.0% | 0.01% | +12.5% |
| Q1 2022 | $9,509,000 | +21.1% | 256,726 | -0.5% | 0.01% | +33.3% |
| Q4 2021 | $7,850,000 | -22.4% | 257,985 | -14.4% | 0.01% | -33.3% |
| Q3 2021 | $10,111,000 | -13.8% | 301,449 | +2.6% | 0.01% | -18.2% |
| Q2 2021 | $11,725,000 | -13.7% | 293,938 | -2.7% | 0.01% | -21.4% |
| Q1 2021 | $13,581,000 | -21.7% | 302,075 | -1.5% | 0.01% | -26.3% |
| Q4 2020 | $17,337,000 | +0.8% | 306,634 | -15.4% | 0.02% | -9.5% |
| Q3 2020 | $17,197,000 | -17.5% | 362,429 | +2.6% | 0.02% | -25.0% |
| Q2 2020 | $20,835,000 | +24.3% | 353,374 | -0.3% | 0.03% | +3.7% |
| Q1 2020 | $16,761,000 | -60.5% | 354,504 | -49.6% | 0.03% | -50.0% |
| Q4 2019 | $42,467,000 | -3.3% | 702,974 | -4.1% | 0.05% | -11.5% |
| Q3 2019 | $43,902,000 | -11.2% | 732,804 | -4.7% | 0.06% | -14.1% |
| Q2 2019 | $49,421,000 | -23.4% | 768,960 | -3.3% | 0.07% | -27.6% |
| Q1 2019 | $64,556,000 | +52.4% | 795,317 | +1.5% | 0.10% | +32.4% |
| Q4 2018 | $42,370,000 | +1.1% | 783,759 | -3.5% | 0.07% | +13.8% |
| Q3 2018 | $41,902,000 | +23.8% | 812,368 | -0.0% | 0.06% | +14.0% |
| Q2 2018 | $33,852,000 | -2.5% | 812,392 | +3.1% | 0.06% | -8.1% |
| Q1 2018 | $34,725,000 | -11.2% | 787,768 | +1.3% | 0.06% | -13.9% |
| Q4 2017 | $39,106,000 | -0.7% | 777,449 | +0.1% | 0.07% | -8.9% |
| Q3 2017 | $39,391,000 | +1.1% | 776,949 | +1.4% | 0.08% | -6.0% |
| Q2 2017 | $38,967,000 | +31.9% | 766,012 | +4.3% | 0.08% | +21.7% |
| Q1 2017 | $29,535,000 | -11.6% | 734,690 | +5.2% | 0.07% | -18.8% |
| Q4 2016 | $33,412,000 | +73.3% | 698,562 | +32.8% | 0.08% | +60.4% |
| Q3 2016 | $19,279,000 | +57.3% | 526,179 | -0.0% | 0.05% | +39.5% |
| Q2 2016 | $12,255,000 | -41.1% | 526,185 | +2.5% | 0.04% | -45.7% |
| Q1 2016 | $20,792,000 | -32.6% | 513,383 | +3.1% | 0.07% | -36.4% |
| Q4 2015 | $30,840,000 | – | 497,974 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |